Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Dermatology (Basel, Switzerland)|June 26, 2007
Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?Maja A Hofmann, Stefanie Hernandez Coll, Ingeborg Küchler, et al.
Pediatric Dermatology|April 5, 2005
Diffuse normolipemic plane xanthoma in a 9-year-old boyMaja Hofmann, Kristina Zappel, Uwe Trefzer, et al.
Melanoma Research|December 24, 2008
Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanomaMaja A Hofmann, Felix Gussmann, Andreas Fritsche, et al.
The Journal of Dermatology|June 11, 2011
Impact of lymph node metastases on serum level of melanoma inhibitory activity in stage III melanoma patientsMaja A Hofmann, Bernd Schicke, Andreas Fritsch, et al.
Cardiovascular Ultrasound|September 6, 2005
Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case reportNicoline Jochmann, Felix Kiecker, Adrian C Borges, et al.
Cancer|October 29, 2009
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanomaTim Eisen, Uwe Trefzer, Anne Hamilton, et al.
Melanoma Research|September 27, 2003
Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG)Christine Zimpfer-Rechner, Udo Hofmann, Robert Figl, et al.
Vaccine|March 10, 2005
Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical resultsUwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
International Journal of Cancer|May 18, 2004
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patientsUwe Trefzer, Gunda Herberth, Karolina Wohlan, et al.
The American Journal of Dermatopathology|September 9, 2005
Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanomaSusanne Reinke, Peter Königer, Gunda Herberth, et al.
Pageof 7